General Information of Drug Therapeutic Target (DTT) (ID: TTJB8UY)

DTT Name HUMAN beta adrenergic receptor (BAR)
Synonyms Beta adrenoreceptor
Gene Name ADRB1
BioChemical Class
G-protein coupled receptor 1 family
UniProt ID
ADRB1_HUMAN ; ADRB2_HUMAN ; ADRB3_HUMAN
TTD ID
T86646
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAG
MGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVV
WGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVC
TVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIM
AFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAP
LANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFV
FFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAARRRHATHGDRPRASGCLARPGP
PPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
Function
Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling. Involved in the regulation of sleep/wake behaviors.
KEGG Pathway
Calcium signaling pathway (hsa04020 )
cGMP-PKG signaling pathway (hsa04022 )
cAMP signaling pathway (hsa04024 )
Neuroactive ligand-receptor interaction (hsa04080 )
Adrenergic signaling in cardiomyocytes (hsa04261 )
Gap junction (hsa04540 )
Regulation of lipolysis in adipocytes (hsa04923 )
Renin secretion (hsa04924 )
Salivary secretion (hsa04970 )
Chemical carcinogenesis - receptor activation (hsa05207 )
Dilated cardiomyopathy (hsa05414 )
Reactome Pathway
G alpha (s) signalling events (R-HSA-418555 )
ADORA2B mediated anti-inflammatory cytokines production (R-HSA-9660821 )
Adrenoceptors (R-HSA-390696 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Approved Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carvedilol DMHTEAO Chronic heart failure BD1Z Approved [1]
------------------------------------------------------------------------------------

References

1 Can beta-adrenergic blockers be used in the treatment of COVID-19 Med Hypotheses. 2020 May 5;142:109809.